Article Text

PDF
Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation
  1. Sook Hee An1,
  2. Eun Mi Lee2,3,
  3. Jae Yeon Kim3,
  4. Hye sun Gwak2,4
  1. 1 College of Pharmacy, Wonkwang University, Iksan, Republic of Korea
  2. 2 Graduate School of Clinical Health Sciences, Ewha Womans University, Seoul, Republic of Korea
  3. 3 Department of Pharmacy, Asan Medical Centre, Seoul, Republic of Korea
  4. 4 College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea
  1. Correspondence to Dr Hye sun Gwak, College of Pharmacy & Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea; hsgwak{at}ewha.ac.kr

Abstract

Objective This study aimed to characterise vancomycin pharmacokinetics in critically ill neonates undergoing extracorporeal membrane oxygenation.

Methods In a retrospective analysis, the pharmacokinetics of vancomycin were determined in 25 full-term neonates receiving extracorporeal membrane oxygenation and compared with those of matched controls (n = 25) not receiving extracorporeal membrane oxygenation.

Results The half-life of vancomycin in the neonates undergoing extracorporeal membrane oxygenation was significantly prolonged compared with that in the controls (17.45 ± 11.01 hour vs 5.92 ± 2.70 hour, P<0.001). Clearance decreased significantly in the extracorporeal membrane oxygenation group relative to the control group (0.03 ± 0.02 L/kg/hr vs 0.08 ± 0.05 L/kg/hr, P<0.001). No significant difference was found in the volume of distribution between the two groups (0.63 ± 0.30 L/kg in the extracorporeal membrane oxygenation group vs 0.57 ± 0.14 L/kg/hr in control, P=0.596). Clearance values were significantly correlated with serum creatinine (r = - 0.528, P<0.001). In the subgroup analysis using patients with serum creatinine < 0.5 mg/dL, similar results were obtained including significantly prolonged half-life (11.52 ± 6.31 hour vs 5.44 ± 2.36 hour, P<0.001) and decreased clearance (0.05 ± 0.02 L/kg/hr vs 0.09 ± 0.05 L/kg/hr, P<0.001) in the extracorporeal membrane oxygenation group relative to the control group.

Conclusions Vancomycin clearance decreased significantly in the neonates undergoing extracorporeal membrane oxygenation compared with the controls. Dosing adjustments of vancomycin and close therapeutic drug monitoring are required for the safe and effective management of neonates during extracorporeal membrane oxygenation.

  • clearance
  • extracorporeal membrane oxygenation
  • neonates
  • pharmacokinetics
  • vancomycin

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.